{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T08:09:52Z","timestamp":1772784592760,"version":"3.50.1"},"reference-count":57,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Asthma"],"published-print":{"date-parts":[[2019,8,3]]},"DOI":"10.1080\/02770903.2018.1500584","type":"journal-article","created":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T09:33:52Z","timestamp":1531474432000},"page":"872-881","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":13,"title":["A cost-effectiveness analysis of reslizumab in the treatment of poorly controlled eosinophilic asthma"],"prefix":"10.1080","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3738-2973","authenticated-orcid":false,"given":"Jenny","family":"Lam","sequence":"first","affiliation":[{"name":"Department of Health Economics, Leonard D. Schaeffer Center for Health Policy and Economics, School of Pharmacy","place":["Los Angeles, USA"]},{"name":", University of Southern California","place":["Los Angeles, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel W.","family":"Hay","sequence":"additional","affiliation":[{"name":"Department of Health Economics, Leonard D. Schaeffer Center for Health Policy and Economics, School of Pharmacy","place":["Los Angeles, USA"]},{"name":", University of Southern California","place":["Los Angeles, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Salcedo","sequence":"additional","affiliation":[{"name":"Department of Health Economics, Leonard D. Schaeffer Center for Health Policy and Economics, School of Pharmacy","place":["Los Angeles, USA"]},{"name":", University of Southern California","place":["Los Angeles, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.","family":"Kenyon","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, University of California","place":["Davis, Sacramento, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,8,29]]},"reference":[{"key":"e_1_3_3_2_1","unstructured":"National Center for Health Statistics Centers for Disease Control and Prevention. Asthma 2017. Available from: http:\/\/www.cdc.gov\/nchs\/fastats\/asthma.htm [last accessed 11 Nov 2017]."},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.3109\/02770903.2014.956894"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2017.23.1.85"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S39119"},{"key":"e_1_3_3_6_1","unstructured":"U.S. Food and Drug Administration Center for Drug Evaluation and Research. Medical Review(s) for Cinqair (reslizumab). 2016. Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2016\/761033Orig1s000MedR.pdf [last accessed 17 Mar 2017]."},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0213-9"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199010113231505"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12905"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12179"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(15)00042-9"},{"key":"e_1_3_3_12_1","unstructured":"Centers for Medicare and Medicaid Services (CMS). ASC Approved HCPCS Code and Payment Rates. 2017. Available from: https:\/\/www.cms.gov\/apps\/ama\/license.asp?file=\/Medicare\/Medicare-Fee-for-Service-Payment\/ASCPayment\/Downloads\/2017-July-ASC-Addenda.zip [last accessed 25 Jun 2017]."},{"key":"e_1_3_3_13_1","unstructured":"U.S. Food and Drug Administration. Cinqair (reslizumab) Label. 2016. Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/761033lbl.pdf [last accessed 17 Mar 2017]."},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/oso\/9780195108248.001.0001"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780190492939.001.0001"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2016.10.028"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2010.02336.x"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2006.01310.x"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.3109\/02770903.2015.1072552"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X132389"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2014.07.009"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200801-060ST"},{"key":"e_1_3_3_23_1","unstructured":"Kochanek KD Murphy SL Xu JQ Tejada-Vera B. Deaths: final data for 2014. National Vital Statistics Reports. National Center for Health Statistics 2016;65. Available from: https:\/\/www.cdc.gov\/nchs\/data\/nvsr\/nvsr65\/nvsr65_04.pdf [last accessed 22 Aug 2017]."},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1159\/000441687"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200601-007OC"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(82)90786-0"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(82)90787-2"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.47.2.76"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/147.4.832"},{"key":"e_1_3_3_30_1","unstructured":"Tsuchiya A Brazier J McColl E Parkin D. Deriving preference-based single indices from non-preference based condition-specific instruments: converting AQLQ into EQ5D indices. Discussion Paper (Unpublished). 2002. Available from: http:\/\/eprints.whiterose.ac.uk\/10952\/ [last accessed 10 Jun 2017]."},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.3132\/pcrj.2007.00002"},{"key":"e_1_3_3_32_1","unstructured":"U.S. Department of Veterans Affair. VA federal supply schedule pharmaceutical pricing. 2017. Available from: https:\/\/www.va.gov\/oal\/business\/fss\/pharmPrices.asp [last accessed 28 Jul 2017]."},{"key":"e_1_3_3_33_1","unstructured":"Centers for Medicare and Medicaid Services (CMS). Physician fee schedule pricing information. 2017. Available from: https:\/\/www.cms.gov\/apps\/physician-fee-schedule\/search\/search-criteria.aspx [last accessed 10 Jun 2017]."},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2015.08.003"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1353\/hpu.2014.0051"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2013.08.012"},{"key":"e_1_3_3_37_1","unstructured":"Agency for Healthcare Research and Quality. HCUP cost-to-charge ratio files (CCR): 2001\u20132009. Available from: http:\/\/www.hcup-us.ahrq.gov\/db\/state\/costtocharge.jsp [last accessed 10 Jun 2017]."},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000410"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.04.010"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2015.07.019"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.2500\/ajra.2012.26.3811"},{"key":"e_1_3_3_42_1","first-page":"567","article-title":"Opportunity costs of ambulatory medical care in the United States","volume":"21","author":"Ray KN","year":"2015","unstructured":"Ray KN, Chari AV, Engberg J, Bertolet M, Mehrotra A. Opportunity costs of ambulatory medical care in the United States. Am J Manag Care 2015;21:567\u2013574.","journal-title":"Am J Manag Care"},{"key":"e_1_3_3_43_1","unstructured":"Unite States Department of Labor Bureau of Labor Statistics (BLS). Employer costs for employee compensation. 2017. Available from: https:\/\/www.bls.gov\/news.release\/pdf\/ecec.pdf [last accessed 28 Jul 2017]."},{"key":"e_1_3_3_44_1","unstructured":"United States Department of Labor Bureau of Labor Statistics (BLS). CPI-all urban consumers (current series) U.S. Medical Care 1982\u201384. Available from: https:\/\/data.bls.gov\/cgi-bin\/surveymost?cu [last accessed 25 Jun 2017]."},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01836-2017"},{"key":"e_1_3_3_46_1","first-page":"1","article-title":"Assessment of geriatric predictors of adherence to zoledronic acid treatment for osteoporosis: a prospective follow-up study","author":"Tasci I","year":"2017","unstructured":"Tasci I, Cintosun U, Safer U, Naharci MI, Bozoglu E, Aydogdu A, Doruk H. Assessment of geriatric predictors of adherence to zoledronic acid treatment for osteoporosis: a prospective follow-up study. Acta Clin Belg 2017;1\u20137.","journal-title":"Acta Clin Belg"},{"key":"e_1_3_3_47_1","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/acr.21638","article-title":"Adherence with intravenous zoledronate and intravenous ibandronate in the United States Medicare population","volume":"64","author":"Curtis JR","year":"2012","unstructured":"Curtis JR, Yun H, Matthews R, Saag KG, Delzell E. Adherence with intravenous zoledronate and intravenous ibandronate in the United States Medicare population. Arthritis Care Res 2012;64:1054\u20131060.","journal-title":"Arthritis Care Res"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy102"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1405158"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e31815c31a7"},{"key":"e_1_3_3_51_1","unstructured":"U.S. Food and Drug Administration Center for Drug Evaluation and Research. Medical review(s) for nucala (mepolizumab). 2015. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2015\/125526Orig1s000MedR.pdf [last accessed 17 Mar 2017]."},{"key":"e_1_3_3_52_1","unstructured":"U.S. Food and Drug Administration Center for Drug Evaluation and Research. Risk Assessment and risk mitigation review(s) for fasenra (Benralizumab). 2017. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2017\/761070Orig1s000RiskR.pdf [last accessed 8 Jan 2018]."},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31324-1"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31322-8"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S78049"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2008.01723.x"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200903-0354OC"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.07.055"}],"container-title":["Journal of Asthma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/02770903.2018.1500584","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:17:54Z","timestamp":1772777874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/02770903.2018.1500584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,29]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8,3]]}},"alternative-id":["10.1080\/02770903.2018.1500584"],"URL":"https:\/\/doi.org\/10.1080\/02770903.2018.1500584","relation":{},"ISSN":["0277-0903","1532-4303"],"issn-type":[{"value":"0277-0903","type":"print"},{"value":"1532-4303","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijas20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijas20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-02-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}